Workflow Services Expands Colorectal Cancer Screening Education Program at Pharmacies
Pilot data from software platform shows unique role of community pharmacy as an emerging healthcare hub that can drive awareness and...
Cancer
ACCC and Lilly Announce Seven Awardees of the Healthcare Improvement Initiative “Improving the Precision Oncology Care Pathway”
ROCKVILLE, Md., March 18, 2025 /PRNewswire/ -- The Association of Cancer Care Centers (ACCC), in collaboration with Eli Lilly and...
“Pick Up Your Poop” F Cancer’s New Campaign Encourages At-Home Colorectal Cancer Screening
Humorous PSA Highlights the Irony of Pet Owners' Willingness to Handle Dog Waste While Avoiding Their Own Screening COSTA MESA, Calif.,...
BillionToOne Celebrates Major Milestone: 1 Million UNITY Tests
UNITY is the only commercially available non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens...
Clearwater Joins CancerX to Help Drive Strong Cybersecurity and Data Privacy Practices in the Fight Against Cancer
New Initiative Part of Company's Mission to Move Organizations Across the Healthcare Ecosystem to a More Secure, Compliant, and Resilient State...
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader...
TOGETHXR and Aflac Put More Ducks in a Row for Women’s Sports
Continued partnership launches Raise the Bar campaign for equal basketball tournament tune-ins from March 17-April 6 TOGETHXR.com published a digital map...
Canopy and Texas Oncology Announce Multi-Year Partnership to Improve Patient Outcomes
NEW YORK, March 18, 2025 /PRNewswire/ -- Canopy, the first Continuous Care Platform for oncology, today announced a multi-year partnership with...
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies
Two IRO Platforms Ori Biotech’s IRO Platform The IRO Platform in Use A scientist uses the IRO Platform 8 IRO...
Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain
-- Company taps first EU distributors, Comercial Medico Quirurigca, SA and Durgalab, as the first globally to be granted rights...
Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain
Opioid-free and addiction-free pain treatment therapy could address $1.5B worldwide CINP marketATLANTA, March 18, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics,...
March 2025 Letter to Shareholders
VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year...
A Guide to Great Skin at Any Age
MISSION, Kan., March 17, 2025 /PRNewswire/ -- (Family Features) Here's the secret for achieving a glowing complexion: there is no...
Baird Medical’s AI Tumor Ablation Surgical Robot Wins “Most Valuable Investment Award,” Pioneering AI and Robotics Integration in Healthcare
NEW YORK, March 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been...
IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals
CAMBRIDGE, United Kingdom, March 17, 2025 /PRNewswire/ -- IgniteData has announced a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) and Cambridge University Hospitals...
PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer
Press release PEP-Therapy receives FDA Orphan Drug Designation for PEP-010for treatment of Pancreatic Cancer Paris (France), March 17, 2025 –...
New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution
Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, favorable...
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
FRANKFURT, Germany and MIAMI, March 17, 2025 (GLOBE NEWSWIRE) -- Partex NV and Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an...
Lirum Therapeutics Announces Debut of LX-101 Results in Thyroid Eye Disease, Selected for Presentation at the 2025 NANOS Annual Meeting
New York, NY, March 17, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on...
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
-- Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new...